Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from CDSCO

How I lost eight out of nine cases before the Chief Information Commissioner

Over the last decade we have read many an obituary about the Right to Information Act. Let me add to that long list of obituaries by narrating how I lost eight out of nine cases before one Information Commissioner – Heeralal Samariya, a former IAS officer who was first appointed…

Newslaundry

No change in status quo for sales and distribution of emergency contraceptive pills

The sales and distribution of Emergency Contraceptive Pill (ECP) brands, including i-Pill and Unwanted - 72, will remain unchanged, sources with the Central Drugs Standard Control Organisation (CDSCO) said on Friday? Read further on Dynamite News:

Dynamite News

India develops Monkeypox detection RT-PCR kit

The World Health Organisation (WHO) has announced its second public health emergency of International concern due to Monkey Pox. Read further on Dynamite News:

Dynamite News

From analysis to the latest developments in health,
read the most diverse news in one place.

TB vaccine MTBVAC gets CDSCO nod for phase II trials

CDSCO approves Bharat Biotech's phase II clinical trial for TB vaccine in India, focusing on safety and immunogenicity.

The Hindu

Drug regulator warns about Meropenem, Disodium

CDSCO warns against unapproved drugs, specifically "New Drugs", citing examples of Meropenem and Disodium EDTA.

The Hindu

Union Cabinet approves memoranda on health products with Netherlands, Dominican Republic, Ecuador

“The Union Cabinet on January 18 approved separate memorandum with the Netherlands, Dominican Republic and Ecuador on cooperation in the field of medical products regulation,” an official statement said.

The Hindu

Exclusive: AAP govt procured drugs from 2 blacklisted pharma firms with many failed quality tests

Six drugs from six pharma firms have fuelled a tussle between the Centre and the Delhi government, with both sides trying to blame each other for substandard medicines making their way to the capital’s government hospitals.

Newslaundry

Read news from The Economist, FT, and more,
with one subscription

Two labs in India take on the bulk of testing for cough syrup samples for export

India is taking steps to ensure quality of drugs exported, with 15 Central and State-run labs testing cough syrup samples for export. CDSCO has increased posts and amended rules to ensure safety and stability of drugs. Private players have also been brought in to speed up process.

The Hindu

Batches of India-manufactured syrups for cough, allergic rhinitis found contaminated: CDSCO

CDSCO report finds two Indian manufacturers' cough and allergy syrups contain contaminants; WHO issued alerts on contaminated cold-cough syrups exported by India. 48 samples declared "not of standard quality" and "spurious" of 1,166 tested in Aug. Gujarat firm asked to suspend production; TN-based firm's COLD OUT syrup found to have…

The Hindu

NHRC alarmed over reported circulation of falsified liver, cancer drugs

After the alert from the WHO, the CDSCO has asked the State regulators, doctors and patients to remain vigilant about two medicines.

The Hindu

Drugs regulator issues alert after pharma firm Abbott India recalls antacid syrup Digene Gel

The public notice issued by the apex drug controller on its website said: “The impugned product may be unsafe and its use may result in adverse reaction.”

The Hindu

Hyderabad-based Bharat Biotech recalls typhoid vaccine batch owing to substandard quality

It added that the recall was initiated utilising the principle of abundant precaution based on test results of field samples by the Central Drugs Laboratory.

The Hindu

CDSCO starts probe into Indian-manufactured eye drops leading to infection

The Central Drugs Standard Control Organisation (CDSCO) has initiated an investigation into a complaint raised by the Sri Lankan Ministry of Health alleging that eyedrops manufactured in India are linked to eye infection in more than 30 people.

The Hindu

Centre considering testing drugs at govt. laboratories before exporting

Amid quality issues being raised globally for the cough syrups exported by Indian firms, the Centre is actively considering a proposal of testing drugs at government laboratories before they are dispatched to other countries.

The Hindu

Get all your
news in one place.

100’s of premium titles.
One news app.

Reuters

Exclusive-India considers policy change after cough syrup deaths - Modi's office

India is considering a change to its pharmaceutical industry policy after cough syrups made in the country were linked to the deaths of children overseas, according to a document from Prime Minister Narendra Modi's office, which noted that "important things" about the industry had been "overlooked".

Newslaundry

Cough syrup deaths: Why is India’s drug regulator going after Dinesh Thakur and T Prashant Reddy?

It’s been over a week since public health activists Dinesh Thakur and T Prashant Reddy received an ominous notice from India’s Central Drugs Standard Control Organisation, warning them to stop “maligning the image of the institution and the nation at large”.

The Hindu

Pharma exporters body suspends membership of Maiden Pharmaceuticals

Pharmexcil had sought details after WHO named the firm in a medical product alert

The Hindu

Gambia deaths | Pharma exporters body asks Maiden to share details

The incident has left a serious dent in the reputation of Indian pharma industry and exports, says Director-General

Get all your
news in one place.

100’s of premium titles.
One news app.

The Hindu

Drug regulator initiates probe after WHO links children deaths in Gambia to cough syrup made in India

Maiden Pharmaceutical Limited is the manufacturer licensed by the State drug controller for the products under reference, and holds manufacturing permission for these products

The Hindu

CDSCO falling short in effectively regulating the medical devices industry: Parliamentary panel

The Committee observed that the country has only 18 certified Medical Device Testing Laboratories that have been approved by CDSCO and that is grossly insufficient keeping in view the size of the country.

The Hindu

Zenara Pharma gets CDSCO nod to make copy of Pfizer’s Paxlovid

Combi pack of Nirmatrelvir, Ritonavir tablets is for patients with moderate symptoms of Covid-19

The Hindu

A new legislation that mirrors the old

The New Drugs, Medical Devices and Cosmetics Bill is antiquated and needs to be revised

The Hindu

First case of infection from diabetes medication in India

State drug controllers told to include warning for patients using SGLT2 inhibitors

The Hindu

Panel recommends regular market approval for Covishield and Covaxin

The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) has recommended granting regular market approval to COVID-19 vaccines, Covishield and Covaxin, in the adul

Newslaundry

The Bedaquiline Question

One of the increasingly contentious public health issues in India is the manner in which clinical trials are conducted for new drugs and the manner in which these new drugs are subsequently approved for use on Indian patients.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the World Health Organisation

129 stories

Jackson

120 stories

Union Health Ministry

118 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.